i-base

News

Featured HTB: issue 10 online (08 June 2018): DTG alert, PK reports and more

Darunavir and heart disease, a controversial review of PrEP, albuvirtide approved in China…

Featured HTB: issue 9 online (21 May 2018): DTG alert and BHIVA/BASHH reports

Contents online PDF of this issue Subscribe by email This issue of HTB leads with worrying reports of a potential signal of neural tube defects in four women taking dolutegravir at the time of conception. Importantly, there is no signal …

Featured U=U: Undetectable = Untransmittable

New Q&A on U=U… Has your doctor talked to you yet?

Questions about U=U: what, when, who, why….?

The following questions provide more information about why an undetectable viral load stops HIV transmission (U=U). What is U=U? U=U is an abbreviation for: Undetectable = Untransmittable It means that someone with an undetectable HIV viral load on HIV treatment …

HTB: issue 8 online (1 May 2018): special BHIVA/BASHH conference issue

4th BHIVA/BASHH conference in Edinburgh… access to services, new guidelines, standards of care, WeLoveKissing…

Featured Modern ART for Africa…

New resources with Treatment Action Campaign on modern ART in Africa…

HTB: issue 7 online (16 April 2018): (Another) special CROI issue

Third set of reports from CROI: pregnancy, adolescent care, drug interactions and side effects…

HTB: issue 6 online (30 March 2018): Special CROI issue

CROI reports: ibalizumab, pregnancy and review cure studies

HTB: issue 5 online (14 March 2018): Special CROI issue

CROI reports: bictegravir, PrEP and TB reports, plus cure-related research

Conference on Retroviruses and Opportunistic Infections (CROI 2018)

First reports: cure studies, new drugs for PrEP and HIV, breaking news for TB care…

HTB: issue 4 online (23 February 2018)

Looking ahead to CROI 2018, global use of dolutegravir, challenges of being transgender and positive…

HTB: issue 3 online (09 February 2018)

New drug approvals, HIV and pregnancy, guidelines and online resources…

London clinic to prescribe generic PrEP privately at £55 for 30 tablets

Simon Collins, HIV i-Base On 10 February 2018, the sexual health clinic at 56 Dean Street in Soho launched a new programme that will provide generic tenofovir DF/emtricitabine, the dual pill that protects against HIV. This will use private prescriptions in …

Featured i-Base 2018 appeal: we need your help…

£4.50 or £9.00 each month will support services this year…

Featured HTB: issue 2 online (22 January 2018)

UK HIV statistics, IMPACT PrEP trial, US guidelines drop use of “HIV infected”…

New format HTB: issue 1 online (05 January 2018)

Best of 2017 review, Sadiq Khan signs London to end AIDS, drug resistance and early ART – register now…

Featured London signed up as a fast-track HIV city by Mayor Sadiq Khan

Simon Collins, HIV i-Base On Wednesday 10 January 2018, Sadiq Khan, the Mayor of London hosted a signing ceremony at City Hall for London to be the second UK city to join the HIV Fast Track City initiative. [1] Other …

Featured 2017: a year in review – why i-Base continues…

Polly Clayden and Simon Collins, HIV i-Base A review of 2017 with the most important news and trends. Hyperlinks in the text are to articles from HIV Treatment Bulletin (HTB) in 2017. Great news is always good to report… Steady …

Fit for Purpose: treatment optimisation reports

Fit for Purpose is an i-Base publication about HIV treatment strategies for low and middle-income countries. This report is currently updated 2-3 times a year, to coincide with main HIV conferences, including CROI, IAS and CADO2. Each report covers treatment …

Featured November/December HTB now online

Reports from EACS 2017, 8th HIV and Ageing Workshop and IAS 2017. Plus journal reviews and other news.

Post navigation